SANOFI BIOTECHNOLOGY

ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES

Educational services, namely, arranging and conducting classes, seminars, conferences, and workshops for patients with immune system related diseases and disorders, namely, asthma, atopic dermatitis, and nasal polyposis, in the fields of immunology and inflammatory diseases;The mark consists of the stylized wording ADVENT below two slightly offset chevrons facing the opposite direction. The stylized wording ADVANCES IN TYPE 2 IMMUNE DISEASES appears below the wording ADVENT.;ADVENT ADVANCES IN TYPE TWO IMMUNE DISEASES; ADVENT ADVANCES IN TYPE TO IMMUNE DISEASES;Color is not claimed as a feature of the mark.;ADVANCES IN TYPE 2 IMMUNE DISEASES;

ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES

Educational services, namely, arranging and conducting classes, seminars, conferences, and workshops for patients with immune system related diseases and disorders, namely, asthma, atopic dermatitis, and nasal polyposis, in the fields of immunology and inflammatory diseases;The mark consists of the stylized wording ADVENT below two slightly offset chevrons facing the opposite direction. The letters AD appear in a dark teal, whereas the letters VENT appear in a light teal. The left-pointing chevron is shaded light gray to dark gray from left to right, and the right-pointing chevron is shaded dark teal to light teal from left to right. A light gray shadow between the two chevrons gives the illusion of depth. The stylized wording ADVANCES IN TYPE 2 IMMUNE DISEASES appears in light gray below the wording ADVENT, the white background represents a transparent area and is not part of the mark.;ADVENT ADVANCES IN TYPE TWO IMMUNE DISEASES; ADVENT ADVANCES IN TYPE TO IMMUNE DISEASES;The color(s) light teal, dark teal, light gray, and dark gray is/are claimed as a feature of the mark.;ADVANCES IN TYPE 2 IMMUNE DISEASES;

ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES

Educational services, namely, arranging and conducting classes, seminars, conferences, and workshops for patients with immune system related diseases and disorders, namely, asthma, atopic dermatitis, and nasal polyposis, in the fields of immunology and inflammatory diseases;The mark consists of the stylized wording ADVENT below two slightly offset chevrons facing the opposite direction. The letters AD appear in a dark teal, whereas the letters VENT appear in a light teal. The left-pointing chevron is shaded light gray to dark gray from left to right, and the right-pointing chevron is shaded dark teal to light teal from left to right. A dark gray shadow between the two chevrons gives the illusion of depth. The stylized wording ADVANCES IN TYPE 2 IMMUNE DISEASES appears in light gray below the wording ADVENT.;ADVENT ADVANCES IN TYPE TWO IMMUNE DISEASES;The color(s) light teal, dark teal, light gray, and dark gray is/are claimed as a feature of the mark.;ADVANCES IN TYPE 2 IMMUNE DISEASES;

ADVENT ATOPIC DERMATITIS ADVANCES IN TYPE 2 IMMUNE DISEASES

Educational services, namely, arranging and conducting classes, seminars, conferences, and workshops for patients with immune system related diseases and disorders, namely, atopic dermatitis, in the fields of immunology and inflammatory diseases;The mark consists of the stylized wording ADVENT below two slightly offset chevrons facing the opposite direction. The letters AD appear in a dark orange, and the letters VENT appear in a light orange. The wording ATOPIC DERMATITIS appears in a stylized light orange font over the wording VENT. The left-pointing chevron is shaded light gray to dark gray from left to right, and the right-pointing chevron is shaded dark orange to light orange from left to right. A shadow in dark gray between the two chevrons gives the illusion of depth. The stylized wording ADVANCES IN TYPE 2 IMMUNE DISEASES appears in light gray below the wording ADVENT.;ADVENT ATOPIC DERMATITIS ADVANCES IN TYPE TWO IMMUNE DISEASES; ADVENT ATOPIC DERMATITIS ADVANCES IN TYPE TO IMMUNE DISEASES;The color(s) light orange, dark orange, light gray, and dark gray is/are claimed as a feature of the mark.;ATOPIC DERMATITIS ADVANCES IN TYPE 2 IMMUNE DISEASES;

ALIRIDUC

Cardiovascular pharmaceuticals;

ARGECEA

Pharmaceutical products for the treatment of autoimmune diseases, inflammatory diseases, rheumatoid arthritis and ankylosing spondylarthritis;

AUTOAIM

Syringes sold filled with pharmaceutical preparations for the treatment of auto-immune disease for human use;AUTO AIM;

DECRELEN

Pharmaceutical products for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; hormones; vitamins; dietetic and food substances adapted for medical use;

DECRELEN

Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders;

DUBALOS

Pharmaceutical products for the treatment of cardiovascular diseases, central and peripheral nervous system diseases, respiratory diseases, cancer, allergies, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, eye diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; hormones; vitamins; dietetic and food substances adapted for medical use;

DUBALOS

Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders;

DUBRANTIS

Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders;

DUPIBASE

DUPI BASE;Refrigerated medical container for storage, transportation and cooling of medicines and pharmaceuticals;Medication containers for personal use, namely, containers for storage of pharmaceuticals requiring refrigeration;

DUPIXENT

Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders;

DUPIXENT

The mark consists of the word DUPIXENT in brown to the left of the design of four arrows pointing right. The first arrow is yellow and connected to the second orange arrow at the bottom by a dark orange line. The third arrow is dark green and is connected to the fourth light green arrow at the top by a green line. White represents background and is not claimed as a feature of the mark.;Pharmaceutical preparations for the treatment of allergies and allergic diseases and disorders, autoimmune diseases and disorders, dermatological diseases and disorders, damaged skin and tissues, gastrointestinal diseases and disorders, inflammation and inflammatory diseases and disorders, respiratory diseases and disorders;The color(s) brown, yellow, dark orange, orange, dark green, green and light green is/are claimed as a feature of the mark.;